Protection from unfair competition on the pharmaceutical market in the conditions of the COVID-19 pandemic

Authors

DOI:

https://doi.org/10.26641/2307-0404.2022.4.271235

Keywords:

medicines, unfair advertising, intellectual property, COVID-19, legal protection, unfair competition

Abstract

The article reveals the problems and prospects of combating dishonest advertising of medicinal products in the conditions of the COVID-19 pandemic. Using the example of the USA and Ukraine, the criteria for banning the advertising of medicinal products by researching scientific sources, international and domestic legal acts, prescriptions and instructions of state bodies, etc. were analyzed. The differences and specifics of the regulatory requirements for the advertising of medicinal products in Ukraine and the USA have been determined. It has been established that in the USA it is allowed to advertise prescription drugs, and in Ukraine a ban has been introduced to advertise "antiviral drugs of direct action". Attention was drawn to the qualification of the division of advertising slogans in the USA, which made it possible to draw an analogy with Ukrainian advertising of medicinal products. It has been proven that individual pharmaceutical manu­facturers, by providing advertisers with incomplete information about the drug, can mislead consumers about its effecti­veness. The Antimonopoly Committee of Ukraine has demonstrated cases of countering the spread of false information about the properties of medicinal products, which became more frequent in connection with the emergence of the strain (SARS-CoV-2) in 2019. The advantages and disadvantages of a complete ban on medicines on television and radio, as well as other mass media are indicated in connection with the entry into force of the decision of the National Security and Defense Council of Ukraine "On the state of the national health care system and urgent measures to ensure the protection of citizens of Ukraine with medical assistance" dated July 30, 2021. As an alternative to the complete rejection of drug advertising it is proposed, the introduction of the mechanism of "corrective advertising", which is actively used in the USA and consists in correcting or making amendments to already published drug advertising and eliminating statements that mislead consumers, contain incomplete, inaccurate, false information about the medicinal product.

References

Prescription Drugs: Medicare Spending on Drugs with Direct-to-Consumer Advertising [Internet]. Wa-shington: U.S. Government Accountability Office (U.S. GAO); 2021 [cited 2022 Aug 12]. Available from: https://www.gao.gov/products/gao-21-380/

[During the year, drug manufacturers spent 7.2 billion hryvnias on advertising]. [Internet]. Eko-nomichna pravda. 2016 Mar 14 [cited 2022 Aug 12]. Ukrainian. Available from: https://www.epravda.com.ua/news/2016/03/14/585194/

Detector.media [Internet]. [The company Ocean Media Plus pointed out the risks for the Ukrainian media market due to the introduction of a moratorium on the advertising of medicinal products]; 2021 Aug 19 [cited 2022 Aug 12]. Ukrainian. Available from: https://detector.media/infospace/article/191295/2021-08-19-kompaniya-ocean-media-plus-vkazala-na-ryzyky-dlya-ukrainskogo-mediarynku-cherez-vvedennya-moratoriyu-na-reklamu-likarskykh-zasobiv/

Volynets I. [Protection against unfair advertising on the drug market. Creation, protection, protection and commercialization of objects of intellectual property rights]. 5th All-Ukrainian scientific and practical conference with international participation; 2022 Apr 26; Kyiv, Ukraine. Kyiv: KPI im. I. Sikorskoho; 2022. p. 358-63. Ukrainian. Available from: https://km.kpi.ua/wp-content/uploads/Zbirnyk-IV-2022.pdf

[On protection against unfair competition: Law of Ukraine of 1996, Pub. No. 236/96-VR. (Oct 16, 2020). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/236/96-vr#Text.

[About advertising: Law of Ukraine of July 3, 1996, Pub. No. 270/96-VR. (Aug 3, 2022). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/270/96-vr#Text

[About some issues of prohibition of advertising of medicinal products: Order of the Ministry of Health of Ukraine of Juny 06, 2012, Pub. No. 422. (Feb 18, 2022). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z1189-12#Text

[On making changes to the Criteria used in the determination of medicinal products, the advertising of which is prohibited: Order of the Ministry of Health of Ukraine of Nov 23, 2021, Pub. No. 2593. (2021). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/z0092-22#Text

Chabarai H. [How to wean Ukrainians from Google therapy. Analytics, security, economics, inter-national politics, culture. Content matters!] [Internet]. Kyiv: Tyzhden. 2018 May 18 [cited 2022 Aug 12]. Ukrainian. Available from: https://tyzhden.ua/Society/214112

Lapii F, Lavrovskyi N, Denysenko A, Shcher-ban O. [Money on the wind: which drugs with dubious effectiveness spend billions of hryvnias in Ukraine and what to do about it]. Ukrainska pravda [Internet]. 2021 Oct 13 [cited 2022 Aug 12]. Ukrainian. Available from: https://life.pravda.com.ua/health/2021/10/13/246197/

Most advertised drugs on U.S. TV 2021. Statista Research Department [Internet]. 2022 Sep 5 [cited 2022 Aug 12]. Available from: https://www.statista.com/statistics/639356/tv-advertise-drugs-usa/

Guttmann A. Pharmaceutical industry TV ad spend in the U.S 2016-2020. Statista [Internet]. 2021 [cited 2022 Aug 12]. Available from: https://www.statista.com/statistics/953104/pharma-industry-tv-ad-spend-us/

Lee B. How Is Consumer Drug Advertising Regulated in the United States? GoodRx Health [Internet]. 2022 July 1 [cited 2022 Aug 12]. Available from: https://www.goodrx.com/healthcare-access/patient-advocacy/prescription-drug-advertising-regulation-united-states

Kracov D, Davar M. International Comparative Legal Guides International Business Reports. Pharma-ceutical Advertising Laws and Regulations Report 2022 USA [Internet]; 2022 [cited 2022 Aug 12]. Available from: https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/usa

Faerber AE, Kreling DH. Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs. Journal of General Internal Medicine. 2013 Sep 13;29(1):110-8. doi: https://doi.org/10.1007/s11606-013-2604-0

[According to the results of the study on the detection and termination of unfair practices in the field of advertising of medicinal products, biologically active additives, medical procedures, antiseptics and disinfectants: Report of the Antimonopoly Committee of Ukraine. Office of Unfair Competition Investigations]. [Internet]. Kyiv; 2020. [cited 2022 Aug 14]. Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5ff/5b9/766/5ff5b976685ac541795869.pdf

[On violation of the legislation on protection against unfair competition: Decision of the Antimonopoly Committee of Ukraine of October 22, 2020, Pub. No. 654-r]. [Internet]; (Oct 22, 2020). Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5f9/fd7/08d/5f9fd708dd9f7819532980.pdf

[On violation of the legislation on protection against unfair competition and imposition of a fine: Decision of the Antimonopoly Committee of Ukraine of July 2, 2020, Pub. No. 421-r]. [Internet]; (Jul 02, 2020). Ukrainian. Available from: https://amcu.gov.ua/storage/app/uploads/public/5f0/852/ae6/5f0852ae6c6f2854410852.pdf

[On violation of the legislation on protection against unfair competition and the imposition of a fine: Decision of the Antimonopoly Committee of Ukraine of July 2, 2020, Pub. No. 430-r]. [Internet]; (Jul 02 2020). Ukrainian. Available from: https://amcu.gov.ua/npas/pro-porushennya-zakonodavstva-pro-zahist-vid-nedobrosovisnoyi-konkurenciyi-ta-nakladennya-shtrafu-5

[Regarding the application of the provisions of Article 151 of the Law of Ukraine "On Protection from Unfair Competition" in relation to the advertising of medicinal products: Recommendation clarifications of the Antimonopoly Committee of Ukraine of March 16, 2021, Pub. No.13-rr]. [Internet]; (2021). Ukrainian. Available from: https://amcu.gov.ua/npas/shchodo-zastosuvannya-polozhen-statti-151-zakonu-ukrayini-pro-zahist-vid-nedobrosovisnoyi-konkurenciyi-stosovno-reklami-likarskih-zasobiv

[On the state of the national health care system and urgent measures to provide citizens of Ukraine with medical aid: Decision of the National Security and Defense Council of Ukraine of July 30, 2021]. [Internet]; (2021). Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/n0052525-21#Text

[Do self-medication now and then: in Ukraine, antibiotics will be sold by electronic prescription]. Vikna [Internet]; 2022 [cited 2022 Aug 12]. Ukrainian. Available from: https://vikna.tv/styl-zhyttya/zdorovia-ta-krasa/z-1-serpnya-v-ukrayini-antybiotyky-prodavatymut-lyshe-za-elektronnym-reczeptom/

[From August 2022, patients will start receiving electronic prescriptions for antibiotics]. [Internet]. Kyiv: Ministry of Health; 2022 [cited 2022 Aug 12]. Ukrainian. Available from: https://moz.gov.ua/article/news/z-serpnja-2022-roku-pacienti-pochnut-otrimuvati-elektronni-recepti-na-antibiotiki.

Aikin KJ, Southwell BG, Paquin RS, Rupert DJ, O'Donoghue AC, Betts KR, Lee PK. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay. Research in Social and Administrative Pharmacy. 2017 Mar;13(2):378-88. doi: https://doi.org/10.1016/j.sapharm.2016.04.004

Corrective advertising [Internet]. Multitran dictionary; 2022 [cited 2022 Aug 12]. Available from: https://www.multitran.com/m.exe?l1=1&l2=2&s=corrective+advertising&langlist=2

Downloads

Published

2022-12-29

How to Cite

1.
Kodynets A, Doroshenko O, Volynets I, Dorozhko G, Petrenko V, Belitsky V. Protection from unfair competition on the pharmaceutical market in the conditions of the COVID-19 pandemic. Med. perspekt. [Internet]. 2022Dec.29 [cited 2024Nov.26];27(4):231-8. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/271235

Issue

Vol. 27 No. 4 (2022)

Section

SOCIAL MEDICINE

License

Copyright (c) 2023 Medicni perspektivi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.

Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.